1. Anti-HIV / HCV Activity of Cyanobacterial Phycobiliproteins by a New Standardized Method Using Bacteriophage Surrogates. Abd El Hamid, M.I., W.M. Abd El Fatah, A.A. El Morsi, M.S. Draz, S. Kallakuri, S. Bungau, L. Endres, C. Bardaca, and E.E. Hafez. Revista de Chimie, 2019. 70(9): p. 3115-3122. ISI[000489958900006].
[WOS]. HIV_10_2019.
2. Discovery of Novel Integrase Inhibitors Acting Outside the Active Site through High-throughput Screening.Aknin, C., E.A. Smith, C. Marchand, M.L. Andreola, Y. Pommier, and M. Metifiot. Molecules, 2019. 24(20): E3675. PMID[31614773].
[PubMed]. HIV_10_2019.
3. Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine. Andersen, P.I., K. Krpina, A. Ianevski, N. Shtaida, E. Jo, J. Yang, S. Koit, T. Tenson, V. Hukkanen, M.W. Anthonsen, M. Bjoras, M. Evander, M.P. Windisch, E. Zusinaite, and D.E. Kainov. Viruses, 2019. 11(10): E964. PMID[31635418].
[PubMed]. HIV_10_2019.
4. New Phosphorus Analogs of Bevirimat: Synthesis, Evaluation of anti-HIV-1 Activity and Molecular Docking Study.Chrobak, E., K. Marciniec, A. Dabrowska, P. Pecak, E. Bebenek, M. Kadela-Tomanek, A. Bak, M. Jastrzebska, and S. Boryczka. International Journal of Molecular Sciences, 2019. 20(20): E5209. PMID[31640137].
[PubMed]. HIV_10_2019.
5. Discovery of Novel 1,4-Disubstituted 1,2,3-Triazole phenylalanine Derivatives as HIV-1 Capsid Inhibitors. Jiang, X.Y., G.C. Wu, W.A. Zalloum, M.E. Meuser, A. Dick, L. Sun, C.H. Chen, D.W. Kang, L.L. Jing, R.F. Jia, S. Cocklin, K.H. Lee, X.Y. Liu, and P. Zhan. RSC Advances, 2019. 9(50): p. 28961-28986. ISI[000487104200008].
[WOS]. HIV_10_2019.
6. Potent Antiviral HIV-1 Protease Inhibitor Combats Highly Drug Resistant Mutant PR20. Kneller, D.W., J. Agniswamy, A.K. Ghosh, and I.T. Weber. Biochemical and Biophysical Research Communications, 2019. 519(1): p. 61-66. PMID[31474336].
[PubMed]. HIV_10_2019.
7. Oleanolic acid Derivatives as Potential Inhibitors of HIV-1 Protease. Medina-O'Donnell, M., F. Rivas, F.J. Reyes-Zurita, M. Cano-Munoz, A. Martinez, J.A. Lupianez, and A. Parra. Journal of Natural Products, 2019. 82(10): p. 2886-2896. PMID[31617361].
[PubMed]. HIV_10_2019.
8. Design and Biological Evaluation of M-Xylene Thioether-Stapled Short Helical Peptides Targeting the HIV-1 gp41 Hexameric Coiled-Coil Fusion Complex. Meng, G., J. Pu, Y. Li, A. Han, Y. Tian, W. Xu, T. Zhang, X. Li, L. Lu, C. Wang, S. Jiang, and K. Liu. Journal of Medicinal Chemistry, 2019. 62(19): p. 8773-8783. PMID[31513410].
[PubMed]. HIV_10_2019.
9. Novel Thiazolidin-4-ones as Potential Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase. Petrou, A., P. Eleftheriou, A. Geronikaki, M.G. Akrivou, and I. Vizirianakis. Molecules, 2019. 24(21): E3821. PMID[31652782].
[PubMed]. HIV_10_2019.
10. Synthesis, anti-HIV Activity, Molecular Modeling Study and QSAR of New Designed 2-(2-Arylidenehydrazinyl)-4-arylthiazoles. Rauf, A., M.K. Kashif, B.A. Saeed, N.A. Al-Masoudi, and S. Hameed. Journal of Molecular Structure, 2019. 1198. ISI[000489331600058].
[WOS]. HIV_10_2019.
11. Synthesis, Characterization: Spectral and Theoretical, Molecular Docking and in Vitro Studies of Copper Complexes with HIV RT Enzyme. Shanty, A.A., K.G. Raghu, and P.V. Mohanan. Journal of Molecular Structure, 2019. 1197: p. 154-163. ISI[000487932000017].
[WOS]. HIV_10_2019.
12. Synthesis, Molecular Modelling and Biological Studies of 3-Hydroxypyrane-4-one and 3-Hydroxy-nyridine-4-one Derivatives as HIV-1 Integrase Inhibitors. Sirous, H., A. Fassihi, S. Brogi, G. Campiani, F. Christ, Z. Debyser, S. Gemma, S. Butini, G. Chemi, A. Grillo, R. Zabihollahi, M.R. Aghasadeghi, L. Saghaie, and H.R. Memarian. Medicinal Chemistry, 2019. 15(7): p. 755-770. PMID[30569867].
[PubMed]. HIV_10_2019.
13. Anti-HIV-1 Activity of Quinic acid Isolated from Helichrysum mimetes Using NMR-based Metabolomics and Computational Analysis. Yazdi, S.E., G. Prinsloo, H.M. Heyman, C.B. Oosthuizen, T. Klimkait, and J.J.M. Meyer. South African Journal of Botany, 2019. 126: p. 328-339. ISI[000489157200037].
[WOS]. HIV_10_2019.
14. Cordidepsine Is a Potential New anti-HIV Depsidone from Cordia millenii, Baker. Zeukang, R.D., X. Siwe-Noundou, M.T. Fotsing, T.T. Kuiate, J.T. Mbafor, R.W.M. Krause, M.I. Choudhary, and A.D. Atchade. Molecules, 2019. 24(17). PMID[31484419]. PMCID[PMC6749241].
[PubMed]. HIV_10_2019.
Patent Citations
15. Preparation of 4-Oxo-3,4-dihydroquinazoline Compds. As Inhibitors of Human Immunodeficiency Virus Replication.Belema, M., J.A. Bender, D.B. Frennesson, E.P. Gillis, C. Iwuagwu, J.F. Kadow, B.N. Naidu, K.E. Parcella, K.M. Peese, R. Rajamani, M.G. Saulnier, and A.X. Wang. Patent. 2019. 2019-IB52990 2019198024: 313pp.
[Patent]. HIV_10_2019.
16. Preparation of Pyrazines and Related Heterocycles as Antiviral Agents and Use Thereof. Botta, M., F. Canducci, V. Cagno, D. Lembo, C. Tintori, A. Brai, and N. Palombi. Patent. 2019. 2019-EP56717 2019175436: 84pp.
[Patent]. HIV_10_2019.
17. Piperizine Derivatives as Pan-tropic Entry Inhibitors and Their Preparation. Liotta, D.C., E. Jecs, Y. Altas Tahirovic, L. Wilson, and S.C. Pelly. Patent. 2019. 2019-US23022 2019183133: 102pp.
[Patent]. HIV_10_2019.